Diminished nuclear‐localized <i>β</i>‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Haibo Ni (ORCID: https://orcid.org/0000-0003-0083-4286)
- Manman Qin
- Ao Shen (ORCID: https://orcid.org/0000-0002-1559-3895)
- Haocheng Lu (ORCID: https://orcid.org/0000-0002-5740-8010)
- Lei Li (ORCID: https://orcid.org/0000-0001-9333-5667)
- Ying Wang (ORCID: https://orcid.org/0000-0002-8566-875X)
- Lei Li (ORCID: https://orcid.org/0000-0003-4433-1277)
- Wenjing Xiang
- Fangyuan Wang (ORCID: https://orcid.org/0000-0002-9880-3930)
- Hualong Yu (ORCID: https://orcid.org/0000-0001-9621-4158)
- Siyuan Ni (ORCID: https://orcid.org/0009-0004-2214-9866)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Southern University of Science and Technology (CN)
- State Key Laboratory of Respiratory Disease (CN)
- University of California, Davis (US)
- Xi'an Jiaotong University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1111/bph.17347
- Citations
- 4
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- National Natural Science Foundation of China